Harris TB, Launer LJ, Eiriksdottir G, et al.Age, Gene/Environment Susceptibility–Reykjavik Study: multidisciplinary applied phenomics. American journal of epidemiology. 165:1076–1087, 2007.
 Kim TH, Lee SS, Yoo JH, et al.The relationship between the regional abdominal adipose tissue distribution and the serum uric acid levels in people with type 2 diabetes mellitus. Diabetology & metabolic syndrome. 4:1, 2012.
 Ford ES, Li C, Cook S, et al.Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 115:2526–2532, 2007.
 Lv Q, Meng X-F, He F-F, et al.High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PloS one. 8:e56864, 2013.
 Gosling AL, Matisoo-Smith E, Merriman TR.Hyperuricaemia in the Pacific: why the elevated serum urate levels? Rheumatology international. 34:743–757, 2014.
 Sun X, Zhang R, Jiang F, et al.Common variants related to serum uric acid concentrations are associated with glucose metabolism and insulin secretion in a Chinese population. PloS one. 10:e0116714, 2015.
 Bartáková V, Kuricová K, Pácal L, et al.Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus. Journal of Diabetes and its Complications. 2016.
 Yuan H, Yang X, Shi X, et al.Association of serum uric acid with different levels of glucose and related factors. Chinese medical journal. 124:1443–1448, 2011.
 Li Y-l, Xie H, Musha H, et al.The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid. Cell Biochemistry and Biophysics. 72:643–647, 2015.
 Khosla UM, Zharikov S, Finch JL, et al.Hyperuricemia induces endothelial dysfunction. Kidney international. 67:1739–1742, 2005.
 Sluijs I, Beulens JW, Spijkerman AM, et al.Plasma uric acid is associated with increased risk of type 2 diabetes independent of diet and metabolic risk factors. The Journal of nutrition. 143:80–85, 2013.
 Yang Q, Guo C-Y, Cupples LA, et al.Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study. Metabolism. 54:1435–1441, 2005.
 Li S, Sanna S, Maschio A, et al.The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 3:e194, 2007.
 Wallace C, Newhouse SJ, Braund P, et al.Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. The American Journal of Human genetics. 82:139–149, 2008.
 Döring A, Gieger C, Mehta D, et al.SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nature genetics. 40:430–436, 2008.
 Evans SA, Doblado M, Chi MM, et al.Facilitative glucose transporter 9 expression affects glucose sensing in pancreatic β-cells. Endocrinology. 150:5302–5310, 2009.
 Hollis‐Moffatt JE, Xu X, Dalbeth N, et al.Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case–control sample sets. Arthritis & Rheumatism. 60:3485–3492, 2009.
 Phipps-Green AJ, Hollis-Moffatt JE, Dalbeth N, et al.A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets. Human molecular genetics. 19:4813–4819, 2010.
 Das Gupta E, Sakthiswary R, Lee SL, et al.Clinical significance of SLC2A9/GLUT9 rs11722228 polymorphisms in gout. International Journal of Rheumatic Diseases. 2016.
 Fadieieva A, Prystupa L, Pogorelova O, et al.[ROLE OF SLC2A9 AND ABCG2 GENE POLYMORPHISMS IN ORIGIN OF HYPERURICEMIA AND GOUT]. Georgian medical news.79–83, 2016.
 Wei F, Chang B, Yang X, et al.Serum Uric Acid Levels were Dynamically Coupled with Hemoglobin A1c in the Development of Type 2 Diabetes. Scientific Reports. 6, 2016.
 Vučak J, Katić M, Bielen I, et al.Association between hyperuricemia, prediabetes, and prehypertension in the Croatian adult population-a cross-sectional study. BMC cardiovascular disorders. 12:1, 2012.
 Krishnan E, Akhras K, Sharma H, et al.Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout. QJM.hct093, 2013.
 Engoren M, Schwann TA, Habib RH.Elevated hemoglobin A1c is associated with readmission but not complications. Asian Cardiovascular and Thoracic Annals. 22:800–806, 2014.
 Ogbera AO, Azenabor AO.Hyperuricaemia and the metabolic syndrome in type 2 DM. Diabetology & metabolic syndrome. 2:1, 2010.
 Wang J, Chen R-P, Lei L, et al.Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients with central obesity in Guangdong Province in China. Asia Pacific journal of clinical nutrition. 22:590–598, 2013.
 Vitart V, Rudan I, Hayward C, et al.SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nature genetics. 40:437–442, 2008.
 Kimura T, Takahashi M, Yan K, et al.Expression of SLC2A9 isoforms in the kidney and their localization in polarized epithelial cells. PloS one. 9:e84996, 2014.
 Sull JW, Park EJ, Lee M, et al.Effects of SLC2A9 variants on uric acid levels in a Korean population. Rheumatology international. 33:19–23, 2013.
 Yan Y-Y, Chen X-g, Wang C, et al.Researching on susceptibility and function of SLC2A9 associated with uric acid: a systematic review.
 Palmer TM, Nordestgaard BG, Benn M, et al.Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. 2013.
 Brandstätter A, Kiechl S, Kollerits B, et al.Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabetes care. 31:1662–1667, 2008.
 Nakagawa T, Hu H, Zharikov S, et al.A causal role for uric acid in fructose-induced metabolic syndrome. American Journal of Physiology-Renal Physiology. 290:F625-F631, 2006.
 Enomoto A, Kimura H, Chairoungdua A, et al.Molecular identification of a renal urate–anion exchanger that regulates blood urate levels. Nature. 417:447–452, 2002.
 Stiburkova B, Sebesta I, Ichida K, et al.Novel allelic variants and evidence for a prevalent mutation in URAT1 causing renal hypouricemia: biochemical, genetics and functional analysis. European Journal of Human Genetics. 21:1067–1073, 2013.
 Dinour D, Gray NK, Ganon L, et al.Two novel homozygous SLC2A9 mutations cause renal hypouricemia type 2. Nephrology Dialysis Transplantation. 27:1035–1041, 2012.
 Brandstätter A, Lamina C, Kiechl S, et al.Sex and age interaction with genetic association of atherogenic uric acid concentrations. Atherosclerosis. 210:474–478, 2010.
 Stark K, Reinhard W, Neureuther K, et al.Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study. PloS one. 3:e1948, 2008.
 Dehghan A, Köttgen A, Yang Q, et al.Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. The Lancet. 372:1953–1961, 2008.
 Urano W, Taniguchi A, Anzai N, et al.Association between GLUT9 and gout in Japanese men. Annals of the rheumatic diseases. 69:932–933, 2010.